Reset Map7 Results
10 Xuefu Road Hi-tech Zone Nanjing Shi, Jiangsu Sheng, 210061 ChinaPharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) is an innovative contract research, development and manufacturing organization (CRDMO). Its core businesses include a rationally designed building blocks collection, supplying from discovery, development to commercial; development and GMP manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. Our evolving mission is leveraging top-notch expertise and innovation in chemistry and new technologies to support partners in accelerating drug discovery and market integration. PharmaBlock (USA), Inc., located in the Greater Philadelphia Area, is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., The company opened its first US facility in the Bay Area of California in 2012 and established US headquarters in Pennsylvania in 2017. With an experienced chemistry team and state-of-the-art equipment, PharmaBlock (USA) is providing a large collection of high-quality and novel building blocks, timely customer service, and process R&D services using new technologies such as flow chemistry and micropacked bed hydrogenation to bring greener, safer, innovative, and cost-efficient solutions to the pharmaceutical industry. PharmaBlock has partnered with most of the top 20 pharmaceutical companies and hundreds of small to medium-sized biotech companies worldwide. In addition to the US facilities, PharmaBlock has three main facilities in China. Its global headquarters is located in Nanjing, Jiangsu Province, China, with 775,000 ft² lab space focusing on the design, synthesis, and supply of lab-scale building blocks, and process R&D of key intermediates and APIs. It has two manufacturing sites located in Zhejiang and Shandong Provinces in China, with around 505 m³ combined reactor volume, ranging from 300 L to 8,000 L of reactor size.
11 Weiqi Road, Hangzhou Bay Shangyu Economic and Technological Development Area, Shaoxing, Zhejiang, 312369, China Zhejiang, Zhejiang, 312369 ChinaPharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) is an innovative contract research, development and manufacturing organization (CRDMO). Its core businesses include a rationally designed building blocks collection, supplying from discovery, development to commercial; development and GMP manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. Our evolving mission is leveraging top-notch expertise and innovation in chemistry and new technologies to support partners in accelerating drug discovery and market integration. PharmaBlock (USA), Inc., located in the Greater Philadelphia Area, is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., The company opened its first US facility in the Bay Area of California in 2012 and established US headquarters in Pennsylvania in 2017. With an experienced chemistry team and state-of-the-art equipment, PharmaBlock (USA) is providing a large collection of high-quality and novel building blocks, timely customer service, and process R&D services using new technologies such as flow chemistry and micropacked bed hydrogenation to bring greener, safer, innovative, and cost-efficient solutions to the pharmaceutical industry. PharmaBlock has partnered with most of the top 20 pharmaceutical companies and hundreds of small to medium-sized biotech companies worldwide. In addition to the US facilities, PharmaBlock has three main facilities in China. Its global headquarters is located in Nanjing, Jiangsu Province, China, with 775,000 ft² lab space focusing on the design, synthesis, and supply of lab-scale building blocks, and process R&D of key intermediates and APIs. It has two manufacturing sites located in Zhejiang and Shandong Provinces in China, with around 505 m³ combined reactor volume, ranging from 300 L to 8,000 L of reactor size.
81 Huasheng Road Nanjing, Jiangsu, 210032 ChinaPharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) is an innovative contract research, development and manufacturing organization (CRDMO). Its core businesses include a rationally designed building blocks collection, supplying from discovery, development to commercial; development and GMP manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. Our evolving mission is leveraging top-notch expertise and innovation in chemistry and new technologies to support partners in accelerating drug discovery and market integration. PharmaBlock (USA), Inc., located in the Greater Philadelphia Area, is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., The company opened its first US facility in the Bay Area of California in 2012 and established US headquarters in Pennsylvania in 2017. With an experienced chemistry team and state-of-the-art equipment, PharmaBlock (USA) is providing a large collection of high-quality and novel building blocks, timely customer service, and process R&D services using new technologies such as flow chemistry and micropacked bed hydrogenation to bring greener, safer, innovative, and cost-efficient solutions to the pharmaceutical industry. PharmaBlock has partnered with most of the top 20 pharmaceutical companies and hundreds of small to medium-sized biotech companies worldwide. In addition to the US facilities, PharmaBlock has three main facilities in China. Its global headquarters is located in Nanjing, Jiangsu Province, China, with 775,000 ft² lab space focusing on the design, synthesis, and supply of lab-scale building blocks, and process R&D of key intermediates and APIs. It has two manufacturing sites located in Zhejiang and Shandong Provinces in China, with around 505 m³ combined reactor volume, ranging from 300 L to 8,000 L of reactor size.
81 Huasheng Road Jiangbei New Area Nanjing, Jiangsu , 210032 ChinaPharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) is an innovative contract research, development and manufacturing organization (CRDMO). Its core businesses include a rationally designed building blocks collection, supplying from discovery, development to commercial; development and GMP manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. Our evolving mission is leveraging top-notch expertise and innovation in chemistry and new technologies to support partners in accelerating drug discovery and market integration. PharmaBlock (USA), Inc., located in the Greater Philadelphia Area, is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., The company opened its first US facility in the Bay Area of California in 2012 and established US headquarters in Pennsylvania in 2017. With an experienced chemistry team and state-of-the-art equipment, PharmaBlock (USA) is providing a large collection of high-quality and novel building blocks, timely customer service, and process R&D services using new technologies such as flow chemistry and micropacked bed hydrogenation to bring greener, safer, innovative, and cost-efficient solutions to the pharmaceutical industry. PharmaBlock has partnered with most of the top 20 pharmaceutical companies and hundreds of small to medium-sized biotech companies worldwide. In addition to the US facilities, PharmaBlock has three main facilities in China. Its global headquarters is located in Nanjing, Jiangsu Province, China, with 775,000 ft² lab space focusing on the design, synthesis, and supply of lab-scale building blocks, and process R&D of key intermediates and APIs. It has two manufacturing sites located in Zhejiang and Shandong Provinces in China, with around 505 m³ combined reactor volume, ranging from 300 L to 8,000 L of reactor size.
725 San Aleso Avenue, Suite #8 Sunnyvale, CA 94085 USAPharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) is an innovative contract research, development and manufacturing organization (CRDMO). Its core businesses include a rationally designed building blocks collection, supplying from discovery, development to commercial; development and GMP manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. Our evolving mission is leveraging top-notch expertise and innovation in chemistry and new technologies to support partners in accelerating drug discovery and market integration. PharmaBlock (USA), Inc., located in the Greater Philadelphia Area, is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., The company opened its first US facility in the Bay Area of California in 2012 and established US headquarters in Pennsylvania in 2017. With an experienced chemistry team and state-of-the-art equipment, PharmaBlock (USA) is providing a large collection of high-quality and novel building blocks, timely customer service, and process R&D services using new technologies such as flow chemistry and micropacked bed hydrogenation to bring greener, safer, innovative, and cost-efficient solutions to the pharmaceutical industry. PharmaBlock has partnered with most of the top 20 pharmaceutical companies and hundreds of small to medium-sized biotech companies worldwide. In addition to the US facilities, PharmaBlock has three main facilities in China. Its global headquarters is located in Nanjing, Jiangsu Province, China, with 775,000 ft² lab space focusing on the design, synthesis, and supply of lab-scale building blocks, and process R&D of key intermediates and APIs. It has two manufacturing sites located in Zhejiang and Shandong Provinces in China, with around 505 m³ combined reactor volume, ranging from 300 L to 8,000 L of reactor size.
800 North 5 Points Road West Chester, PA, 19380 United StatesPharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) is an innovative contract research, development and manufacturing organization (CRDMO). Its core businesses include a rationally designed building blocks collection, supplying from discovery, development to commercial; development and GMP manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. Our evolving mission is leveraging top-notch expertise and innovation in chemistry and new technologies to support partners in accelerating drug discovery and market integration. PharmaBlock (USA), Inc., located in the Greater Philadelphia Area, is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., The company opened its first US facility in the Bay Area of California in 2012 and established US headquarters in Pennsylvania in 2017. With an experienced chemistry team and state-of-the-art equipment, PharmaBlock (USA) is providing a large collection of high-quality and novel building blocks, timely customer service, and process R&D services using new technologies such as flow chemistry and micropacked bed hydrogenation to bring greener, safer, innovative, and cost-efficient solutions to the pharmaceutical industry. PharmaBlock has partnered with most of the top 20 pharmaceutical companies and hundreds of small to medium-sized biotech companies worldwide. In addition to the US facilities, PharmaBlock has three main facilities in China. Its global headquarters is located in Nanjing, Jiangsu Province, China, with 775,000 ft² lab space focusing on the design, synthesis, and supply of lab-scale building blocks, and process R&D of key intermediates and APIs. It has two manufacturing sites located in Zhejiang and Shandong Provinces in China, with around 505 m³ combined reactor volume, ranging from 300 L to 8,000 L of reactor size.
777 Schwab Rd, Unit D Hatfield, PA, 19440 United StatesPharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) is an innovative contract research, development and manufacturing organization (CRDMO). Its core businesses include a rationally designed building blocks collection, supplying from discovery, development to commercial; development and GMP manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. Our evolving mission is leveraging top-notch expertise and innovation in chemistry and new technologies to support partners in accelerating drug discovery and market integration. PharmaBlock (USA), Inc., located in the Greater Philadelphia Area, is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., The company opened its first US facility in the Bay Area of California in 2012 and established US headquarters in Pennsylvania in 2017. With an experienced chemistry team and state-of-the-art equipment, PharmaBlock (USA) is providing a large collection of high-quality and novel building blocks, timely customer service, and process R&D services using new technologies such as flow chemistry and micropacked bed hydrogenation to bring greener, safer, innovative, and cost-efficient solutions to the pharmaceutical industry. PharmaBlock has partnered with most of the top 20 pharmaceutical companies and hundreds of small to medium-sized biotech companies worldwide. In addition to the US facilities, PharmaBlock has three main facilities in China. Its global headquarters is located in Nanjing, Jiangsu Province, China, with 775,000 ft² lab space focusing on the design, synthesis, and supply of lab-scale building blocks, and process R&D of key intermediates and APIs. It has two manufacturing sites located in Zhejiang and Shandong Provinces in China, with around 505 m³ combined reactor volume, ranging from 300 L to 8,000 L of reactor size.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.